(Q43817116)

27 November 2017

Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis (English)

1 reference

27 November 2017

0 references

Malena Cohen-Cymberknoh

1

object named as

Malena Cohen-Cymberknoh

1 reference

27 November 2017

3

David Shoseyov

1 reference

27 November 2017

Yasmin Yaakov

2

1 reference

27 November 2017

Eyal Shteyer

4

1 reference

27 November 2017

Edna Schachar

5

1 reference

27 November 2017

Joseph Rivlin

6

1 reference

27 November 2017

Lea Bentur

7

1 reference

27 November 2017

Elie Picard

8

1 reference

27 November 2017

Micha Aviram

9

1 reference

27 November 2017

Eran Israeli

10

1 reference

27 November 2017

Eitan Kerem

11

1 reference

27 November 2017

Michael Wilschanski

12

1 reference

27 November 2017

2 May 2012

1 reference

27 November 2017

Pediatric Pulmonology

1 reference

27 November 2017

48

1 reference

27 November 2017

3

1 reference

27 November 2017

229-235

1 reference

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report

27 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Patterns of GI disease in adulthood associated with mutations in the CFTR gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Cystic fibrosis: terminology and diagnostic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Nasal potential difference measurements in patients with atypical cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Intestinal current measurements to diagnose cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Cystic fibrosis mutations in Israeli Arab patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

Nonclassic cystic fibrosis and CFTR-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

CFTR Cl− channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22586

21 January 2018

Identifiers

DOI

10.1002/PPUL.22586

1 reference

27 November 2017

1 reference